• 1
    Greenberg M, Filler RM. Hepatic tumors. In: PizzoPA, PoplackDG, editors. Principles and practice of pediatric oncology, 2nd ed. Philadelphia: JB Lippincott Company, 1993; 697711.
  • 2
    Stringer MD, Hennayake S, Howard ER, et al. Improved outcome for children with hepatoblastoma. Br J Surg. 1995; 82: 386391.
  • 3
    Evans AE, Land VJ, Newton WA, Randolph JG, Sather HN, Tefft M. Combination chemotherapy (vincristine, Adriamycin, cyclophosphamide, and 5-fluorouracil) in the treatment of children with malignant hepatoma. Cancer. 1982; 50: 821826.
  • 4
    Exelby PR, Filler RM, Grosfeld JL. Liver tumors in children in the particular reference to hepatoblastoma and hepatocellular carcinoma: American Academy of Pediatrics Surgical Section Survey-1974. J Pediatr Surg. 1975; 10: 329337.
  • 5
    Haas JE, Muczynski KA, Krailo M, et al. Histopathology and prognosis in childhood hepatoblastoma and hepatocarcinoma. Cancer. 1989; 64: 10821095.
  • 6
    Lack EE, Neave C, Vawter GF. Hepatocellular carcinoma. Review of 32 cases in childhood and adolescence. Cancer. 1983; 52: 15101515.
  • 7
    Edmondson HA. Differential diagnosis of tumors and tumor-like lesions of liver in infancy and childhood. Arch Dis Child. 1956; 1: 168186.
  • 8
    Farhi DC, Shikes RH, Murari PJ, Silverberg SG. Hepatocellular carcinoma in young people. Cancer. 1983; 52: 15161525.
  • 9
    Berman MM, Libbey NP, Foster JH. Hepatocellular carcinoma. Polygonal cell type with fibrous stroma—an atypical variant with a favorable prognosis. Cancer. 1980; 46: 14481455.
  • 10
    Stromeyer FW, Ishak KG, Gerber MA, Mathew T. Ground-glass cells in hepatocellular carcinoma. Am J Clin Pathol. 1980; 74: 254258.
  • 11
    Craig JR, Peters RL, Edmondson HA, Omata M. Fibrolamellar carcinoma of the liver: a tumor of adolescents and young adults with distinctive clinico-pathologic features. Cancer. 1980; 46: 372379.
  • 12
    Epstein BE, Pajak TF, Haulk TL, Herpst JM, Order SE, Abrams RA. Metastatic nonresectable fibrolamellar hepatoma: prognostic features and natural history. Am J Clin Oncol. 1999; 22: 2228.
  • 13
    Soreide O, Czerniak A, Bradpiece H, Bloom S, Blumgart L. Characteristics of fibrolamellar hepatocellular carcinoma. A study of nine cases and a review of the literature. Am J Surg. 1986; 151: 518523.
  • 14
    Ortega JA, Douglass EC, Feusner JH, et al. Randomized comparison of cisplatin/vincristine/fluorouracil and cisplatin/continuous infusion doxorubicin for treatment of pediatric hepatoblastoma: a report from the Children's Cancer Group and the Pediatric Oncology Group. J Clin Oncol. 2000; 18: 26652675.
  • 15
    Katzenstein HM, Krailo MD, Malogolowkin MH, et al. Hepatocellular carcinoma in children and adolescents: results from the Pediatric Oncology Group and the Children's Cancer Group Intergroup study. J Clin Oncol. 2002; 20: 27892797.
  • 16
    Kaplan E, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc. 1958; 457481.
  • 17
    Kalbfleisch J, Prentice R. The statistical analysis of failure time data. New York: John Wiley & Sons, 1980.
  • 18
    Bishop YMM, Feinberg SE, Holland PMW. Discrete multivariate analysis. Cambridge: MIT Press, 1975.
  • 19
    Giacomantonio M, Ein SH, Mancer K, Stephens CA. Thirty years of experience with pediatric primary malignant liver tumors. J Pediatr Surg. 1984; 19: 523526.
  • 20
    Starzl TE, Iwatsuki S, Shaw BW Jr., Nalesnik MA, Farhi DC, Van Thiel DH. Treatment of fibrolamellar hepatoma with partial or total hepatectomy and transplantation of the liver. Surg Gynecol Obstet. 1986; 162: 145148.
  • 21
    Garcia de Davila MT, Gonzalez-Crussi F, Mangkornkanok M. Fibrolamellar carcinoma of the liver in a child: ultrastructural and immunohistologic aspects. Pediatr Pathol. 1987; 7: 319331.
  • 22
    Zografos GN, Palmer S, Papastratis G, Habib NA. Aggressive surgical management of fibrolamellar hepatocellular carcinoma in puberty. Eur J Surg Oncol. 1997; 23: 570572.
  • 23
    Wetzel WJ, Costin JL, Petrino RL. Fibrolamellar carcinoma: distinctive clinical and morphologic variant of hepatoma. South Med J. 1983; 76: 796798.
  • 24
    Paradinas FJ, Melia WM, Wilkinson ML, et al. High serum vitamin B12 binding capacity as a marker of the fibrolamellar variant of hepatocellular carcinoma. Br Med J (Clin Res Ed). 1982; 285: 840842.
  • 25
    Hany MA, Betts DR, Schmugge M, et al. A childhood fibrolamellar hepatocellular carcinoma with increased aromatase activity and a near triploid karyotype. Med Pediatr Oncol. 1997; 28: 136138.
  • 26
    Debray D, Pariente D, Fabre M, Foucaud P, Valayer J, Bernard O. Fibrolamellar hepatocellular carcinoma: report of a case mimicking a liver abscess. J Pediatr Gastroenterol Nutr. 1994; 19: 468472.
  • 27
    Agarwal VR, Takayama K, Van Wyk JJ, Sasano H, Simpson ER, Bulun SE. Molecular basis of severe gynecomastia associated with aromatase expression in a fibrolamellar hepatocellular carcinoma. J Clin Endocrinol Metab. 1998; 83: 17971800.
  • 28
    Gruner BA, DeNapoli TS, Andrews W, Tomlinson G, Bowman L, Weitman SD. Hepatocellular carcinoma in children associated with Gardner syndrome or familial adenomatous polyposis. J Pediatr Hematol Oncol. 1998; 20: 274278.
  • 29
    Gauthier F, Valayer J, Thai BL, Sinico M, Kalifa C. Hepatoblastoma and hepatocarcinoma in children: analysis of a series of 29 cases. J Pediatr Surg. 1986; 21: 424429.
  • 30
    Lefkowitch JH, Muschel R, Price JB, Marboe C, Braunhut S. Copper and copper-binding protein in fibrolamellar liver cell carcinoma. Cancer. 1983; 51: 97100.
  • 31
    Vecchio FM, Fabiano A, Ghirlanda G, Manna R, Massi G. Fibrolamellar carcinoma of the liver: the malignant counterpart of focal nodular hyperplasia with oncocytic change. Am J Clin Pathol. 1984; 81: 521526.
  • 32
    An T, Ghatak N, Kastner R, Kay S, Lee HM. Hyaline globules and intracellular lumina in a hepatocellular carcinoma. Am J Clin Pathol. 1983; 79: 392396.
  • 33
    Albukerk J. Hepatocellular carcinoma in young adults. NY State J Med. 1981; 81: 13411343.
  • 34
    Misugi K, Okajima H, Misugi N, Newton WA. Classification of primary malignant tumors of liver in infancy and childhood. Cancer. 1967; 20: 17601771.
  • 35
    Teitelbaum DH, Tuttle S, Carey LC, Clausen KP. Fibrolamellar carcinoma of the liver. Review of three cases and the presentation of a characteristic set of tumor markers defining this tumor. Ann Surg. 1985; 202: 3641.
  • 36
    Caballero T, Aneiros J, Lopez-Caballero J, Gomez-Morales M, Nogales F. Fibrolamellar hepatocellular carcinoma. An immunohistochemical and ultrastructural study. Histopathology. 1985; 9: 445456.